fashion -WSS

fashion

author：focus 2025-09-30 19:27:12 - browse：6188

Daphne Koller -- biotech coverage from STAT — Daphne Koller, early biotech AI entrant Insitro's founder, CEO and board member. Courtesy Jerrick Mitra/Insitro

New artificial intelligence technologies made headlines last year for their ability to do everything from generating fake musical duets to understanding how proteins fold. But in biotech, one of the most well-funded AI players has been quiet.

Insitro, a South San Francisco firm, was founded in 2018 by Daphne Koller, who had previously been a Stanford professor, a 2004 MacArthur “genius” grant recipient, and the co-founder and co-CEO of the online course company Coursera. It raised more than $643 million in venture capital, according to PitchBook, from investors including T. Rowe Price, ARCH Venture Partners, and Casdin Capital. The company now has more than 260 employees spread out over 107,000 square feet of laboratory and office space.

But what exactly is Koller building?

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： Bring on the sabbaticals for nurses

focus

WSS

Why is France rioting? What to know about the fatal police shooting of Nahel M

Adam's Take: Intra

6 surprising facts about sugar

Connecting traumatic brain injury and domestic violence

Meta looks to target Twitter with a rival app called Threads

A new study asks: Are we harming blood donors by taking blood?

Wikipedia

fashion

Wikipedia

Psychedelics group wrestles with new pharma identity

Pfizer, Moderna say biotech, pharma drug development is a sprint

The cancer drug shortage isn’t new — and neither are the solutions

Russia says it foiled Ukrainian drone attack on Moscow as Kyiv's counteroffensive grinds on

Guidelines to prevent youth baseball injuries need more muscle

Erich Jarvis studies song birds to learn about human stuttering

Continuity nursing helped my family in our darkest PICU moments

Doctor appointment wait times are getting worse

Moonlake's readout produced a cash windfall. Risks remain

Pfizer, Moderna say biotech, pharma drug development is a sprint

hotspot

Chinese researcher claims birth of first gene

Yancopoulos of Regeneron works to expand Dupixent success

Surgeons perform first xenotransplant using CRISPR'd pig kidney

These geoengineering technologies could help combat the climate crisis, scientists say

7 people shot in DC, police say

Yancopoulos of Regeneron works to expand Dupixent success

entertainment

focus

focus

Wikipedia